
Predilife S.A (ALPRE) | Stock Overview & Key Data
Predilife S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €24.00 on April 29, 2024
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Predilife S.A ALPRE | 12.80M Small-cap | -4.52% | -6.11% | -8.40% | -11.05% | -5.06% | -28.69% | -44.59% | -54.32% |
bioMérieux S.A BIM | 14.53B Large-cap | 0.48% | 4.79% | 7.78% | 8.43% | 21.42% | 28.16% | 22.08% | -9.64% |
Eurofins Scientific ERF | 11.98B Large-cap | 0.82% | 11.36% | 18.42% | 28.90% | 36.27% | 25.78% | -12.14% | 1.43% |
Eurofins Cerep SAS ALECR | 88.77M Small-cap | -3.83% | 0.00% | -14.56% | -14.56% | -10.20% | -10.66% | -13.73% | 162.69% |
Klea Holding ALKLH | 59.69M Small-cap | 0.00% | 5.56% | 5.56% | 0.00% | 11.76% | 11.76% | 0.00% | 0.00% |
Lumibird S.A LBIRD | 441.19M Mid-cap | 4.51% | 8.84% | 69.83% | 159.21% | 105.21% | 98.59% | -10.05% | 64.72% |
Ownership & Short Interest
Predilife S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Predilife S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALPRE's 52-week high and low?
- In the last 52 weeks, Predilife S.A reached a high of €5.85 (on October 3, 2024) and a low of €3.01 (on July 16, 2025).
- What is the market cap and P/E ratio for ALPRE?
- Curious about Predilife S.A's size and valuation? Its market capitalization stands at 12.80M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -2.21.
- Does ALPRE pay dividends? If so, what's the yield?
- As for dividends, Predilife S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Predilife S.A's main competitors or similar companies to consider before investing?
When looking at Predilife S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return bioMérieux S.A
BIM14.53B Healthcare Diagnostics & Research 28.16% 22.08% Eurofins Scientific
ERF11.98B Healthcare Diagnostics & Research 25.78% -12.14% Eurofins Cerep SAS
ALECR88.77M Healthcare Diagnostics & Research -10.66% -13.73% Klea Holding
ALKLH59.69M Healthcare Diagnostics & Research 11.76% 0.00% Lumibird S.A
LBIRD441.19M Healthcare Diagnostics & Research 98.59% -10.05% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Predilife S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Predilife S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -4,653.75%, the Debt to Equity ratio from the most recent quarter is -1.16, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALPRE?
- Looking at Predilife S.A's growth, its revenue over the trailing twelve months (TTM) was €493K. Compared to the same quarter last year (YoY), quarterly revenue grew by 134.50%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALPRE stock is held by insiders and institutions?
- Wondering who owns Predilife S.A stock? Company insiders (like executives and directors) hold about 72.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.